We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$40.8B
AUM Growth
+$3.42B
(+9.2%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
25.28%
Holding
2,151
New
303
Increased
1,108
Reduced
653
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$197M |
| 2 |
Walmart Inc
WMT
|
+$193M |
| 3 |
NextEra Energy
NEE
|
+$177M |
| 4 |
Apple
AAPL
|
+$129M |
| 5 |
UnitedHealth
UNH
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$230M |
| 2 |
Sysco
SYY
|
+$164M |
| 3 |
Synopsys
SNPS
|
+$81.2M |
| 4 |
C.H. Robinson
CHRW
|
+$53.8M |
| 5 |
United Bankshares
UBSI
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.01% |
| 2 | Consumer Staples | 11.62% |
| 3 | Industrials | 10.88% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Healthcare | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
California Resources
CRC
$4.75B
| $756K | ﹤0.01% |
14,405
+3,786
| +36% | +$191K |
|
|
GMS
902
DELISTED
GMS Inc
GMS
| $756K | ﹤0.01% |
8,344
+2,179
| +35% | +$193K |
|
|
PRMW
903
DELISTED
Primo Water Corporation
PRMW
| $753K | ﹤0.01% |
29,836
+8,860
| +42% | +$198K |
|
904
Manhattan Associates
MANH
$8.97B
| $751K | ﹤0.01% |
2,670
-233
| -8% | -$59.3K |
|
905
WEX
WEX
$6.11B
| $751K | ﹤0.01% |
3,582
+1,606
| +81% | +$299K |
|
906
World Kinect Corp
WKC
$1.96B
| $750K | ﹤0.01% |
24,278
+15,070
| +164% | +$417K |
|
907
International Bancshares
IBOC
$4.77B
| $750K | ﹤0.01% |
12,547
+2,824
| +29% | +$173K |
|
908
Credo Technology Group
CRDO
$39.7B
| $749K | ﹤0.01% |
24,332
+7,675
| +46% | +$229K |
|
909
Royalty Pharma
RPRX
$26.1B
| $749K | ﹤0.01% |
26,481
-1,366
| -5% | -$37.8K |
|
910
Cavco Industries
CVCO
$4.39B
| $747K | ﹤0.01% |
1,745
+467
| +37% | +$184K |
|
911
Watsco Inc
WSO
$14.9B
| $746K | ﹤0.01% |
1,517
+8
| +0.5% | +$3.85K |
|
912
Prestige Consumer Healthcare
PBH
$2.35B
| $745K | ﹤0.01% |
10,335
+2,662
| +35% | +$189K |
|
913
FormFactor
FORM
$8.11B
| $743K | ﹤0.01% |
16,151
+4,268
| +36% | +$213K |
|
914
PBF Energy
PBF
$7.29B
| $742K | ﹤0.01% |
23,969
+4,202
| +21% | +$153K |
|
915
Sensient Technologies
SXT
$5.4B
| $741K | ﹤0.01% |
9,239
-92,084
| -91% | -$6.99M |
|
916
Steven Madden
SHOO
$3.12B
| $741K | ﹤0.01% |
15,127
+3,847
| +34% | +$171K |
|
917
Hecla Mining
HL
$10.2B
| $740K | ﹤0.01% |
111,012
+29,107
| +36% | +$170K |
|
918
Tanger
SKT
$4.82B
| $739K | ﹤0.01% |
22,270
+6,064
| +37% | +$177K |
|
919
StepStone Group
STEP
$3.48B
| $738K | ﹤0.01% |
12,982
+4,563
| +54% | +$232K |
|
|
P
920
Everpure Inc
P
$24.8B
| $734K | ﹤0.01% |
14,611
-17,217
| -54% | -$973K |
|
921
Northern Oil and Gas
NOG
$2.3B
| $733K | ﹤0.01% |
20,706
+7,081
| +52% | +$270K |
|
922
Rhythm Pharmaceuticals
RYTM
$7B
| $731K | ﹤0.01% |
13,958
+3,042
| +28% | +$146K |
|
923
Tidewater
TDW
$3.91B
| $730K | ﹤0.01% |
10,166
+2,970
| +41% | +$259K |
|
924
Granite Construction
GVA
$5.45B
| $728K | ﹤0.01% |
9,182
+2,389
| +35% | +$168K |
|
925
Texas Pacific Land
TPL
$28.9B
| $726K | ﹤0.01% |
2,463
-171
| -6% | -$46.9K |
|
Similar funds
ProShare Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, ProShare Advisors held 2,151 positions worth $40.8B, up 9.2% from $37.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
ProShare Advisors's Q3 2024 filing shows 303 new, 1,108 increased, 653 reduced and 86 closed positions. Its largest new stake was NexPoint Residential Trust: 319,514 shares worth $14.1M. The largest sale was Qualcomm, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Consumer Staples and Industrials.
- ProShare Advisors's largest Q3 2024 buy was NexPoint Residential Trust: 319,514 shares worth $14.1M.
- ProShare Advisors added most to West Pharmaceutical in Q3 2024, an estimated $197M increase.
- ProShare Advisors's biggest Q3 2024 reduction was Qualcomm, cutting an estimated $230M.
- ProShare Advisors fully exited Atrion Corp in Q3 2024, selling an estimated $8.02M.
- ProShare Advisors's ten largest holdings make up 25% of its $40.8B portfolio in Q3 2024.
- ProShare Advisors opened 303 new positions and closed 86 in Q3 2024.
- ProShare Advisors's portfolio value rose 9.2% quarter-over-quarter to $40.8B.
Based on ProShare Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.